70 million revenueNobilis is hard to track, so many short sellers its insane for such a small cap health company.
Following them for several years it seems they are flying under the radar when it comes to growth and revenue stream. Debt levels are more than acceptable.
When it pops, we will all forget about the controversy and uncertainty.
Health care is been in the dumps for so long it seems like the good days are long forgotten.
( that's when its time to pull the trigger. )
Then again, i'm not priviledged to inside info, who knows where they will be next year.